Cilostazol add-on therapy in patients with mild dementia receiving donepezil: a retrospective study.
<h4>Goal</h4>Combinatorial therapy directed at both vascular and neurodegenerative aspects of dementia may offer a promising strategy for treatment of dementia, which often has a multifactorial basis in the elderly. We investigated whether the phosphodiesterase III inhibitor cilostazol,...
Main Authors: | Masafumi Ihara, Madoka Nishino, Akihiko Taguchi, Yumi Yamamoto, Yorito Hattori, Satoshi Saito, Yukako Takahashi, Masahiro Tsuji, Yukiko Kasahara, Yu Takata, Masahiro Okada |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24586841/pdf/?tool=EBI |
Similar Items
-
Cilostazol, a Phosphodiesterase 3 Inhibitor, Moderately Attenuates Behaviors Depending on Sex in the Ts65Dn Mouse Model of Down Syndrome
by: Masahiro Tsuji, et al.
Published: (2020-04-01) -
DONEPEZIL THERAPY OF UNDIFFERENTIATED DEMENTIA IN CLINICAL PRACTICE
by: Y. V. Zhitkova, et al.
Published: (2017-12-01) -
Pharmacological Potential of Cilostazol for Alzheimer’s Disease
by: Kenjiro Ono, et al.
Published: (2019-05-01) -
Donepezil in vascular dementia: a randomized, placebo-controlled study
by: Wilkinson, D., et al.
Published: (2003) -
A novel mouse model of ischemic carotid artery disease.
by: Yorito Hattori, et al.
Published: (2014-01-01)